Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for Pediatric Pulmonary Hypertension
NCT00981591Phase 2Withdrawn
- Sponsor
- Seattle Children's
- Start
- Sep 2009
- Primary completion
- Mar 2013
01
Overview
A Phase 2 trial of iloprost in pulmonary hypertension (PH), sponsored by Seattle Children's. Planned start Sep 2009; status: withdrawn.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00981591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981591.